Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Lab Chip ; 24(9): 2454-2467, 2024 Apr 30.
Article in English | MEDLINE | ID: mdl-38644805

ABSTRACT

Safe, accurate, and reliable analysis of urinary biomarkers is clinically important for early detection and monitoring of the progression of chronic kidney disease (CKD), as it has become one of the world's most prevalent non-communicable diseases. However, current technologies for measuring urinary biomarkers are either time-consuming and limited to well-equipped hospitals or lack the necessary sensitivity for quantitative analysis and post a health risk to frontline practitioners. Here we report a robust paper-based dual functional biosensor, which is integrated with the clinical urine sampling vial, for the simultaneous and quantitative analysis of pH and glucose in urine. The pH sensor was fabricated by electrochemically depositing IrOx onto a paper substrate using optimised parameters, which enabled an ultrahigh sensitivity of 71.58 mV pH-1. Glucose oxidase (GOx) was used in combination with an electrochemically deposited Prussian blue layer for the detection of glucose, and its performance was enhanced by gold nanoparticles (AuNPs), chitosan, and graphite composites, achieving a sensitivity of 1.5 µA mM-1. This dual function biosensor was validated using clinical urine samples, where a correlation coefficient of 0.96 for pH and 0.98 for glucose detection was achieved with commercial methods as references. More importantly, the urine sampling vial was kept sealed throughout the sample-to-result process, which minimised the health risk to frontline practitioners and simplified the diagnostic procedures. This diagnostic platform, therefore, holds high promise as a rapid, accurate, safe, and user-friendly point-of-care (POC) technology for the analysis of urinary biomarkers in frontline clinical settings.


Subject(s)
Biosensing Techniques , Paper , Point-of-Care Systems , Humans , Hydrogen-Ion Concentration , Gold/chemistry , Glucose/analysis , Urinalysis/instrumentation , Glucose Oxidase/chemistry , Glucose Oxidase/metabolism , Electrochemical Techniques , Metal Nanoparticles/chemistry , Graphite/chemistry , Biomarkers/urine
2.
Open Access Maced J Med Sci ; 7(20): 3391-3394, 2019 Oct 30.
Article in English | MEDLINE | ID: mdl-32002058

ABSTRACT

BACKGROUND: The high incidence of diabetes mellitus in Indonesia to encourage researchers to continue to develop detection techniques are easy, inexpensive and minimally invasive. This study is expected to answer the challenge. Detection tool used in this research is the detection devices use traditional breath acetone levels of chitosan-based sensors. Acetone breath sensor works based on the chemical interaction between the breath of patients with diabetes and acetone sensor surface, which causes a change in the electrical response. AIM: This study was cross-sectional using diabetes mellitus patients as research subjects by measuring breath acetone levels and HbA1c and KGD as a comparison. METHODS: Research conducted at the primary health care facilities network services the University Hospital of North Sumatra. A total of 58 diabetic patients who meet the inclusion and exclusion criteria were included in this study. The relationship between the measurements analysed using Pearson correlation test. RESULTS: Measurements showed that statistically there is a great relationship between breath acetone levels with or KGD HbA1c levels in the diabetic patient with each R = 0.05 and p = 0.708 for the relationship acetone breath and HbA1c and R = 0.1 and p = 0.445 for the relationship acetone breath and KGD. However, clinically there is a linear relationship between increased levels consistent acetone in the breath with increased HbA1c levels as well as levels of KGD. CONCLUSION: Examination of breath acetone levels can be considered as an indicator of diabetes detection.

SELECTION OF CITATIONS
SEARCH DETAIL
...